Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Kari Ranta"'
Autor:
Talal Ashour, Sami Azar, Akram Echtay, Muhammad Farooqi, Tarek Fiad, Mohamed Hassanein, Ahmed Hassoun, Abdul Jabbar, Amin Jayyousi, Kari Ranta, Hani Sabbour, Fatih Tangi, Ibrahim Turfanda
Publikováno v:
Dubai Diabetes and Endocrinology Journal, Pp 1-11 (2023)
Background: Current guidelines recommend that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) with proven cardiovascular benefit should be considered for first-line therapy in patients with type 2 diabetes (T2D) who have/are at high risk of ath
Externí odkaz:
https://doaj.org/article/716fdb93783548ef97d665013e406f57
Autor:
Oliver Schnell, Tadej Battelino, Richard Bergenstal, Andreas L. Birkenfeld, Antonio Ceriello, Alice Cheng, Melanie Davies, Steve Edelman, Thomas Forst, Francesco Giorgino, Jennifer Green, Per-Henrik Groop, Samy Hadjadj, Hiddo J.L.Heerspink, Marcus Hompesch, Baruch Izthak, Linong Ji, Naresh Kanumilli, Boris Mankovsky, Chantal Mathieu, Martin Miszon, Reem Mustafa, Michael Nauck, Roberto Pecoits-Filho, Jeremy Pettus, Kari Ranta, Helena W. Rodbard, Peter Rossing, Lars Ryden, Petra-Maria Schumm-Draeger, Scott D. Solomon, Jan Škrha, Pinar Topsever, Tina Vilsbøll, John Wilding, Eberhard Standl
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-12 (2023)
Abstract The 8th Cardiovascular Outcome Trial (CVOT) Summit on Cardiovascular, Kidney, and Glycemic Outcomes was held virtually on November 10–12, 2022. Following the tradition of previous summits, this reference congress served as a platform for i
Externí odkaz:
https://doaj.org/article/d2025af878514bcdbba126d73d787a44
Autor:
Ildiko Lingvay, Alice YY. Cheng, Joshua A. Levine, Elisa Gomez‐Valderas, Sheryl E. Allen, Kari Ranta, Amelia Torcello‐Gómez, Vivian T. Thieu
Publikováno v:
Diabetes, Obesity and Metabolism. 25:965-974
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44b9100485c8591346d316ae62857998
https://doi.org/10.1111/dom.14943
https://doi.org/10.1111/dom.14943
Autor:
Alice Y.Y. Cheng, Ildiko Lingvay, Pratik Choudhary, Elisa Gomez Valderas, Sheryl Elaine Allen, Kari Ranta, Joshua A Levine, Vivian Thuyanh Thieu, Sebastian M. Meyhöfer
Publikováno v:
Diabetologie und Stoffwechsel.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96860a7f40485d932a4a6a67becdaddf
https://doi.org/10.1055/s-0043-1767999
https://doi.org/10.1055/s-0043-1767999
Autor:
Joshua A Levine, Alice Y.Y. Cheng, Ildiko Lingvay, Elisa Gomez Valderas, Sheryl Elaine Allen, Kari Ranta, Vivian Thuyanh Thieu, Andreas Hamann
Publikováno v:
Diabetologie und Stoffwechsel.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a0c636eedd9556261ea9d3c70c787da
https://doi.org/10.1055/s-0043-1767976
https://doi.org/10.1055/s-0043-1767976
Autor:
Ildiko, Lingvay, Alice Yy, Cheng, Joshua A, Levine, Elisa, Gomez-Valderas, Sheryl E, Allen, Kari, Ranta, Amelia, Torcello-Gómez, Vivian T, Thieu
Publikováno v:
Diabetes, obesitymetabolism.
To assess composite endpoints combining glycemic control (HbA1c7.0%, ≤6.5%, or5.7%) with weight loss (≥5%, ≥10%, or ≥15%) and without hypoglycemia with tirzepatide in type 2 diabetes (T2D).Data from the phase 3 SURPASS program were evaluated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::63c548ff78e67bd5edeabb97f070b468
https://pubmed.ncbi.nlm.nih.gov/36514843
https://pubmed.ncbi.nlm.nih.gov/36514843
Autor:
Pamela Kushner, John E. Anderson, Jörg Simon, Kristina S. Boye, Kari Ranta, Amelia Torcello-Gómez, Joshua A. Levine
This article reviews the efficacy and safety data of tirzepatide, a once-weekly, novel glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 (GLP-1) receptor agonist approved in the United States, the European Union, and other regi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5bbc941f3bf685c9006eec4560ef2c4
https://doi.org/10.2337/figshare.21424614.v1
https://doi.org/10.2337/figshare.21424614.v1
Autor:
Sheryl Elaine Allen, Alice Cheng, Pratik Choudhary, Joshua A Levine, Kari Ranta, Vivian Thuyanh Thieu, Elisa Gomez Valderas, Ildiko Lingvay
Publikováno v:
Journal of the Endocrine Society. 6:A347-A348
Introduction Tirzepatide, the novel dual GIP/GLP-1 receptor agonist for the treatment of type 2 diabetes, has been shown to reduce HbA1c and weight, with more patients achieving HbA1c ≤6.5%, compared to placebo and active comparators in the phase 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e8fd6192671634334d4a414a193289c
https://doi.org/10.1210/jendso/bvac150.722
https://doi.org/10.1210/jendso/bvac150.722
Autor:
Vivian Thieu, Ildiko Lingvay, Pratik Choudhary, Alice Cheng, Elisa Gomez-Valderas, Sheryl Allen, Kari Ranta, Joshua Levine
Publikováno v:
Endocrine Practice. 28:S24-S25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d74bc1e9e3bddf20390cb775f8cb9b7c
https://doi.org/10.1016/j.eprac.2022.03.074
https://doi.org/10.1016/j.eprac.2022.03.074
Publikováno v:
Acta Paediatrica. 110:993-994
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::469bccf2335f4d830a8b97c98157f991
https://doi.org/10.1111/apa.15569
https://doi.org/10.1111/apa.15569